Microbial membrane and cellular proteins

Microbial membrane and cellular proteins encompass a broad array of structural and functional molecules critical to the life cycle of pathogens, including bacteria, fungi, and viruses. These targets are fundamental to maintaining cellular integrity, facilitating nutrient transport, and executing metabolic processes necessary for survival and virulence (StatPearls, 2023). In clinical practice, these proteins are the primary focus of antimicrobial agents; for instance, beta-lactam antibiotics target penicillin-binding proteins to inhibit cell wall synthesis, while lipopeptides like daptomycin disrupt the bacterial cytoplasmic membrane (Nature Reviews Microbiology, 2017). Because many of these proteins lack direct human homologs, they offer a high degree of selectivity, though systemic toxicity can still occur if the drug cross-reacts with host membranes or metabolic pathways (PubMed, 2021). The therapeutic landscape for these targets is continuously shaped by the emergence of resistance, where microbes modify their membrane composition or cellular proteins to evade drug action (WHO, 2023). This category is considered too broad for a single therapeutic target entry as it aggregates thousands of distinct proteins across different kingdoms of life.

Other names

Bacterial cell wall proteinsMicrobial surface proteinsPathogen-associated molecular patternsMicrobial membrane-associated proteinsBacterial membrane proteins

Drugs targeting these components typically act by inhibiting cell wall biosynthesis, disrupting membrane integrity, or interfering with essential cellular processes like protein synthesis or DNA replication.